Table 2.
Lipid formulations classification systems (LFCS) utilized and the % (w/w) composition of excipients in each formulation in this study.
| LFCS type | No. | Formulation | Oil (%w) |
Surfactant (%w) |
||||
|---|---|---|---|---|---|---|---|---|
| C70 | K70 | CMCM | I742 | TO106V | HCO30 | |||
| I | F1a | C70 | 100 | – | – | – | – | – |
| F2b | K70 | – | 100 | – | – | – | – | |
| IIIA | F2a | C70:CMCM(7:3)/TO106V(1/1) | 35 | – | 15 | – | 50 | – |
| F2b | K70:I742(7:3)/TO106V(1/1) | – | 35 | – | 15 | 50 | – | |
| F3a | C70:CMCM(7:3)/HCO-30(1/1) | 35 | – | 15 | – | – | 50 | |
| F3b | K70:I742(7:3)/HCO-30(1/1) | – | 35 | – | 15 | – | 50 | |
| IIIB | F4a | CMCM/HCO30 (1/1) | – | – | 50 | – | – | 50 |
| F4b | I742/ HCO-30 (1/1) | – | – | – | 50 | – | 50 | |